Literature DB >> 1324441

Protein kinase C activator phorbol 12, 13-dibutyrate inhibits platelet activating factor-stimulated Ca2+ mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells.

T L Yue1, J L Gu, G Feuerstein.   

Abstract

The protein kinase C (PKC) activator, phorbol 12, 13-dibutyrate (PDBu) dose-dependently inhibited platelet-activating factor (PAF)-induced [Ca2+]i elevation and inositol monophosphate (IP1) accumulation in neurohybrid NG108-15 cells with IC50 values of 162 nM and 35 nM, respectively. Pretreatment of NG108-15 cells with PKC inhibitor H-7 partially prevented the inhibitory effect of PDBu on PAF-induced [Ca2+]i elevation as well as PI metabolism in NG108-15 cells. Pretreatment of the cells with pertussis toxin (PTX) resulted in a dose-dependent inhibition of PAF-induced IP1 and IP3 accumulation but only slightly affected PAF-induced [Ca2+]i elevation in NG108-15 cells. The results reveal that PAF receptor-mediated Ca2+ mobilization and PI metabolism in NG108-15 cells are regulated by PKC while a PTX-sensitive G protein is coupled to PAF receptor for inducing activation of phospholipase C.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324441     DOI: 10.1007/bf00966827

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  32 in total

1.  Acetylcholine-induced production of platelet-activating factor by human fetal brain cells in culture.

Authors:  V Sogos; F Bussolino; E Pilia; S Torelli; F Gremo
Journal:  J Neurosci Res       Date:  1990-12       Impact factor: 4.164

Review 2.  The protein kinase C family: heterogeneity and its implications.

Authors:  U Kikkawa; A Kishimoto; Y Nishizuka
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

Review 3.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

Review 4.  Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases.

Authors:  U T Rüegg; G M Burgess
Journal:  Trends Pharmacol Sci       Date:  1989-06       Impact factor: 14.819

Review 5.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

6.  Phorbol esters increase insulin binding in astrocytic glial but not neuronal cells in primary culture from the brain.

Authors:  L M Mudd; M K Raizada
Journal:  Brain Res       Date:  1990-06-25       Impact factor: 3.252

7.  Effect of endothelins on cytosolic free calcium concentration in neuroblastoma NG108-15 and NCB-20 cells.

Authors:  T L Yue; M M Gleason; P G Lysko; G Feuerstein
Journal:  Neuropeptides       Date:  1990-09       Impact factor: 3.286

8.  Phorbol 12-myristate 13-acetate inhibits binding of leukotriene B4 and platelet-activating factor and the responses they induce in neutrophils: site of action.

Authors:  M Yamazaki; J Gomez-Cambronero; M Durstin; T F Molski; E L Becker; R I Sha'afi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  PAF antagonist ginkgolide B reduces postischemic neuronal damage in rat brain hippocampus.

Authors:  H Oberpichler; D Sauer; C Rossberg; H D Mennel; J Krieglstein
Journal:  J Cereb Blood Flow Metab       Date:  1990-01       Impact factor: 6.200

10.  Phorbol ester-induced upregulation of angiotensin II receptors in neuronal cultures is potentiated by a calcium ionophore.

Authors:  C Sumners; S M Rueth; L M Myers; C J Kalberg; F T Crews; M K Raizada
Journal:  J Neurochem       Date:  1988-07       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.